Less invasive lymph node surgery for early-stage breast cancer
Part of Cancer, Skin clinical trials.
This trial is testing a less invasive approach to checking and treating the lymph nodes under the arm in early-stage breast cancer. It may help you avoid unnecessary surgery and its side effects while still ensuring your cancer is properly treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 55 or older and have gone through menopause.
- You have early-stage, hormone receptor positive, HER2 negative breast cancer (or a very early form called DCIS with microinvasion).
- Your tumor is no larger than 3 cm and has not spread to the lymph nodes under your arm.
- You are planning to have breast-conserving surgery (lumpectomy) and radiation to the whole breast afterward.
- You have not had chemotherapy or other systemic treatment before surgery, and you have not had invasive breast cancer before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether some women with early-stage, low-risk breast cancer can safely skip lymph node surgery and, in some cases, radiation. It aims to reduce side effects while keeping cancer control the same.
This trial studies whether you can safely avoid a lymph node biopsy in the armpit for early breast cancer when scans and exams look negative. It may reduce surgery-related side effects while still keeping cancer care on track.
This trial tests whether older women with early-stage, slow-growing breast cancer can safely skip removal of underarm lymph nodes during surgery. The goal is to reduce surgery-related side effects while maintaining safety.
This trial tests if it's safe to skip a sentinel lymph node biopsy (a procedure to check if cancer has spread to the lymph nodes under your arm) when the breast tumor has completely disappeared after chemotherapy. If the trial finds it's safe, you could avoid this extra surgery and its side effects.
This study looks at whether it's safe to do less extensive lymph node surgery (removing only the sentinel node instead of all lymph nodes) for breast cancer that has spread to lymph nodes, after chemotherapy has shrunk the cancer. The goal is to reduce side effects while still effectively treating the cancer.
This study tests a way to decide whether women with early breast cancer and one or two affected lymph nodes can safely skip full lymph node removal. It uses a special biopsy to guide surgery and reduce side effects.
Hear when a new Omitting Sentinel Lymph Node Biopsy in Early-stage Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.